CN Patent

CN113004286B — 作为血浆激肽释放酶抑制剂的三环类化合物及其用途

Assigned to CHENGDU KANGHONG PHARMACEUTICAL CO LTD · Expires 2022-08-12 · 4y expired

What this patent protects

本发明提供一种结构新颖、活性好、选择性高的三环类血浆激肽释放酶抑制剂化合物，可广泛用于涉及血浆激肽释放酶活性相关的疾病的预防或治疗。

USPTO Abstract

本发明提供一种结构新颖、活性好、选择性高的三环类血浆激肽释放酶抑制剂化合物，可广泛用于涉及血浆激肽释放酶活性相关的疾病的预防或治疗。

Drugs covered by this patent

Patent Metadata

Patent number
CN113004286B
Jurisdiction
CN
Classification
—
Expires
2022-08-12
Drug substance claim
No
Drug product claim
No
Assignee
CHENGDU KANGHONG PHARMACEUTICAL CO LTD
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.